Skip to content

Randomized Controlled Study on the Effects of Diacylglycerol (DAG) on Body Fat and Blood Lipids

Randomized Controlled Study on the Effects of Diacylglycerol (DAG) on Body Fat and Blood Lipids

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124248
Enrollment
Unknown
Registered
2026-05-09
Start date
2025-11-22
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elevated blood lipid margin

Interventions

Control group:Replace household cooking oil with placebo (rapeseed oil), take 30 grams daily for 8 consecutive weeks.
Experimental group:Replace household cooking oil with the test substance (diglyceride oil), take 30 grams daily for 8 consecutive weeks.

Sponsors

Suzhou Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18-65 years old, both genders are eligible; 2. BMI >= 30 kg/m^2, or total fat percentage: for men > 25%, for women > 30%; 3. Abnormal blood lipids: 5.18 mmol/L <= serum total cholesterol <= 6.21 mmol/L, or 1.70 mmol/L <= serum triglycerides <= 2.25 mmol/L; 4. Sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women, as well as those with pregnancy plans during the trial period; 2. Individuals with allergic constitution or who are allergic to glycerol diesters; 3. Those with severe diseases such as heart, liver, kidney and hematopoietic system disorders, and patients with mental illnesses; 4. Patients with hyperlipidemia. 5. Those who have taken lipid-lowering drugs in the past two weeks and whose judgment of the results is affected: Lipid-lowering drugs include: • Statins (such as Atorvastatin, Rosuvastatin) • Cholesterol absorption inhibitors (such as Ezetimibe) • Bile acid sequestrants (such as Fenofibrate, Bezafibrate) • Other drugs determined by the researchers to potentially affect the research results 6. Researchers consider the subjects to have poor compliance, or researchers consider that the subjects have any other conditions that are not suitable for participating in this trial.

Design outcomes

Primary

MeasureTime frame
Body fat content;Blood lipid;

Secondary

MeasureTime frame
Weight;Adverse events and serious adverse events;Exercise Status Questionnaire Survey;72-hour dietary questionnaire survey;Renal function;Liver function;Blood routine test;Blood lipid;Subcutaneous fat thickness;Hip circumference;Waist circumference;Body Mass Index;

Countries

China

Contacts

Public ContactZhang Jianwei

Suzhou Municipal Hospital

zjw80_0@163.com+86 512 6236 2613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026